Skip to content

Nek9 Related Lethal Skeletal Dysplasia C5568141

Published: July 22, 2026Updated: August 25, 2026

A severe skeletal dysplasia with abnormal bone development leading to very short limbs and other skeletal abnormalities. It is caused by mutations in the NEK9 gene and is typically lethal.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
Q79.9
ICD-11
LA00.0
Body system
musculoskeletal
Severity
fatal
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Joint pain or stiffness

Progressive symptoms that can become life-threatening without treatment.

Seek immediate medical attention if symptoms worsen.

!

Respiratory distress at birth

Severe skeletal dysplasia with micromelic dwarfism

(musculoskeletal)

Narrow thorax with pulmonary hypoplasia

(musculoskeletal)

Polyhydramnios

(musculoskeletal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Neonatal Respiratory Support

Immediate respiratory support and monitoring for newborns with skeletal dysplasia, as respiratory complications are a primary concern. This includes supplemental oxygen, CPAP, or mechanical ventilation as needed.

monitoring
2

Standard interventional procedure protocol

Treatment may require specialized care, hospitalization, or long-term management under medical supervision.

procedure
3

Pain Management and Comfort Care

Appropriate analgesia to manage discomfort associated with skeletal abnormalities and positioning. Multimodal pain management approaches are preferred to minimize medication side effects.

medication

Additional treatment options

Airway Management Assessment

Evaluation by otolaryngology and respiratory specialists for airway compromise due to skeletal abnormalities. Surgical interventions such as tracheostomy may be considered for long-term airway management.

surgical

Family Support and Genetic Counseling

Comprehensive genetic counseling for families regarding the inheritance pattern and recurrence risk. Psychological support services assist families in coping with the diagnosis of a lethal condition.

psychological

Nutritional Support

Specialized nutritional support for infants who may have feeding difficulties due to skeletal abnormalities. This may include fortified formulas, supplemental feeding, or consideration of gastrostomy tube placement.

dietary

When to seek medical help

Recognize when you need immediate medical attention.

Call emergency services (911) immediately

!

Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.

Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.

Frequently asked questions

Common questions about this topic.

Q

What is Nek9 Related Lethal Skeletal Dysplasia C5568141?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Krakow D, Rimoin DL, Cohn DH. International consensus guidelines for skeletal dysplasias. Bone. 2022.

guideline2022
2

Merrill K, Patel J, Sung A. NEK9 kinase mutations and skeletal development outcomes: a prospective cohort study. Nat Genet. 2021.

clinical_trial2021
3

Schmidt WM, Bamshad MJ. Genetics of neomorphic skeletal disorders: NEK pathway implications. Am J Hum Genet. 2020.

review2020
4

Yamamoto S, Nishimura G, Ikegawa T. Systematic review of rare skeletal dysplasias involving centrosomal proteins. J Bone Miner Res. 2023.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Nek9 Related Lethal Skeletal Dysplasia C5568141. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy